Phase 2 Study Of SU011248 As Consolidation Therapy In Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer
Latest Information Update: 17 Sep 2021
At a glance
- Drugs Sunitinib (Primary) ; Carboplatin; Paclitaxel
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Sponsors Pfizer
- 17 Dec 2009 Planned number of patients changed from 83 to 84 as reported by ClinicalTrials.gov.
- 17 Dec 2009 Actual end date (Oct 2009) added as reported by ClinicalTrials.gov.
- 17 Dec 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.